AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Develops and markets medicines, focusing on respiratory and cardiovascular treatments.

001540 | KO

Overview

Corporate Details

ISIN(s):
KR7001540004
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동, 과천시

Description

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-02 00:00
대표이사변경
Korean 12.3 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.3 MB
2024-11-12 00:00
대표이사변경
Korean 12.2 KB
2024-11-05 00:00
주식등의대량보유상황보고서(일반)
Korean 91.9 KB
2024-10-31 00:00
[기재정정]감사보고서제출 (2020 사업연도)
Korean 32.9 KB
2024-10-31 00:00
[기재정정]감사보고서제출 (2021사업연도)
Korean 32.9 KB
2024-10-31 00:00
[기재정정]사업보고서 (2020.12)
Korean 2.1 MB
2024-10-31 00:00
[기재정정]사업보고서 (2021.12)
Korean 2.3 MB
2024-10-31 00:00
[기재정정]사업보고서 (2022.12)
Korean 2.0 MB
2024-10-31 00:00
[기재정정]사업보고서 (2023.12)
Korean 1.8 MB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.3 MB
2024-07-02 00:00
주식등의대량보유상황보고서(일반)
Korean 85.3 KB
2024-06-05 00:00
주식등의대량보유상황보고서(일반)
Korean 85.3 KB
2024-05-16 00:00
분기보고서 (2024.03)
Korean 1.2 MB

Automate Your Workflow. Get a real-time feed of all AHN-GOOK PHARMACEUTICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AHN-GOOK PHARMACEUTICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AHN-GOOK PHARMACEUTICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.